3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroendocrine Tumors
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Interventions
Fluorouracil
7
Oxaliplatin
6
Nivolumab
5
Leucovorin
5
fludarabine
4
Cyclophosphamide
4
Capecitabine
4
zimberelimab
3
pembrolizumab
3
aldesleukin
3
Trastuzumab
3
Paclitaxel
3
Docetaxel
3
ulixertinib
2
trastuzumab deruxtecan
2
fludarabine phosphate
2
Specimen Handling
2
Ramucirumab
2
Irinotecan
2
zolbetuximab
1
zanidatamab
1
trifluridine tipiracil drug combination
1
trastuzumab biosimilar HLX02
1
trametinib
1
tislelizumab
1
sodium propionate
1
sapanisertib
1
relatlimab
1
quemliclustat
1
propionic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
pazopanib
×
30 days
×
Clear all
No trials found.